Alex Nisthal

Person

Morovia, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterodimeric antibodies that bind fibroblast activation protein
- Patent number 12,180,302
- Issue date Dec 31, 2024
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 12,152,076
- Issue date Nov 26, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Untargeted and targeted IL-10 Fc-fusion proteins
- Patent number 12,006,345
- Issue date Jun 11, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind prostate specific membrane antig...
- Patent number 11,919,956
- Issue date Mar 5, 2024
- Xencor, Inc.
- John R. Desjarlais
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heterodimeric antibodies that bind CD3 and GPC3
- Patent number 11,859,012
- Issue date Jan 2, 2024
- Xencor, Inc.
- Alex Nisthal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CLDN6
- Patent number 11,739,144
- Issue date Aug 29, 2023
- Xencor, Inc.
- Matthew S. Faber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific binding agents binding to CLDN18.2 and CD3
- Patent number 11,739,145
- Issue date Aug 29, 2023
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA...
- Patent number 11,618,776
- Issue date Apr 4, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,492,407
- Issue date Nov 8, 2022
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heterodimeric antibodies that bind ENPP3 and CD3
- Patent number 11,472,890
- Issue date Oct 18, 2022
- Xencor, Inc.
- Rumana Rashid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 11,312,770
- Issue date Apr 26, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,236,170
- Issue date Feb 1, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind fibroblast activation protein
- Patent number 10,982,006
- Issue date Apr 20, 2021
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 10,787,518
- Issue date Sep 29, 2020
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD28 X ANTI-ENPP3 ANTIBODIES
- Publication number 20250084186
- Publication date Mar 13, 2025
- Xencor, Inc.
- Alex Nisthal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...
- Publication number 20240417466
- Publication date Dec 19, 2024
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240400675
- Publication date Dec 5, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TSLPR (CRLF2) ANTIBODIES
- Publication number 20240360233
- Publication date Oct 31, 2024
- Board of Regents, The University of Texas System
- Dongxing ZHA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CLAUDIN18.2 AND CD3
- Publication number 20240247062
- Publication date Jul 25, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240228608
- Publication date Jul 11, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IL18-FC FUSION PROTEINS
- Publication number 20240166705
- Publication date May 23, 2024
- Xencor, Inc.
- Alex NISTHAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240132584
- Publication date Apr 25, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3
- Publication number 20240034815
- Publication date Feb 1, 2024
- Xencor, Inc.
- Alex Nisthal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3
- Publication number 20240018234
- Publication date Jan 18, 2024
- Astellas Pharma Europe BV
- Matthew BERNETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...
- Publication number 20230340053
- Publication date Oct 26, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-18-FC FUSION PROTEINS
- Publication number 20230146665
- Publication date May 11, 2023
- Xencor, Inc.
- Alex Nisthal
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3
- Publication number 20230137677
- Publication date May 4, 2023
- Astellas Pharma Europe BV
- Matthew BERNETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
- Publication number 20230041377
- Publication date Feb 9, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3
- Publication number 20220306767
- Publication date Sep 29, 2022
- Xencor, Inc.
- Alex Nisthal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20220289839
- Publication date Sep 15, 2022
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES
- Publication number 20220204624
- Publication date Jun 30, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND TGFbetaRII
- Publication number 20220144956
- Publication date May 12, 2022
- Xencor, Inc.
- John R. Desjarlais
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...
- Publication number 20220119525
- Publication date Apr 21, 2022
- Xencor, Inc.
- John R. Desjarlais
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN
- Publication number 20210253736
- Publication date Aug 19, 2021
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
UNTARGETED AND TARGETED IL-10 FC-FUSION PROTEINS
- Publication number 20210171596
- Publication date Jun 10, 2021
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3
- Publication number 20200317814
- Publication date Oct 8, 2020
- Xencor, Inc.
- Rumana Rashid
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...
- Publication number 20200247862
- Publication date Aug 6, 2020
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN
- Publication number 20200165356
- Publication date May 28, 2020
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
- Publication number 20190389954
- Publication date Dec 26, 2019
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
- Publication number 20190382495
- Publication date Dec 19, 2019
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES
- Publication number 20190263909
- Publication date Aug 29, 2019
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
- Publication number 20180118836
- Publication date May 3, 2018
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Alex Nisthal

Person

Patents Grantslast 30 patents

Heterodimeric antibodies that bind fibroblast activation protein

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Untargeted and targeted IL-10 Fc-fusion proteins

Heterodimeric antibodies that bind prostate specific membrane antig...

Heterodimeric antibodies that bind CD3 and GPC3

Heterodimeric antibodies that bind CD3 and CLDN6

Bispecific binding agents binding to CLDN18.2 and CD3

Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA...

Bispecific checkpoint inhibitor antibodies

Heterodimeric antibodies that bind ENPP3 and CD3

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Bispecific checkpoint inhibitor antibodies

Heterodimeric antibodies that bind fibroblast activation protein

Bispecific checkpoint inhibitor antibodies

Patents Applicationslast 30 patents

ANTI-CD28 X ANTI-ENPP3 ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

ANTI-TSLPR (CRLF2) ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND CLAUDIN18.2 AND CD3

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

IL18-FC FUSION PROTEINS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3

BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3

TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...

IL-18-FC FUSION PROTEINS

BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES

HETERODIMERIC ANTIBODIES THAT BIND TGFbetaRII

HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...

HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN

UNTARGETED AND TARGETED IL-10 FC-FUSION PROTEINS

HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3

TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...

HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES